Ogurtsov, P P <br/><br/>
[PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].  [electronic resource] 

 -  Klinicheskaia meditsina  2016 
 - 224-30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0023-2149 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Blood Group Antigens--analysis<br/>Drug Therapy, Combination--methods<br/>Female<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Interferons<br/>Interleukins--genetics<br/>Liver Cirrhosis--etiology<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Polymorphism, Genetic<br/>Predictive Value of Tests<br/>Prognosis<br/>Recombinant Proteins--therapeutic use<br/>Reproducibility of Results<br/>Ribavirin--therapeutic use